Cancer Market Research Reports & Industry Analysis

... , technological know - how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 567 ...

... , technological know - how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 585 ...

... , technological know - how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 570 ...

... , technological know - how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 585 ...

... , technological know - how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 590 ...

... , technological know - how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 565 ...

... , technological know - how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 575 ...

... , technological know - how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 620 ...

... (test volumes, sales forecasts, supplier shares) $21,100. “Future Horizons and Growth Strategies in the Global Cancer Diagnostics Market 2015” is a new seven-country ... developing new cancer diagnostic tests and detection technologies. Competitive Strategies Strategic assessments of major suppliers and start-up firms developing innovative ...

... (test volumes, sales forecasts, supplier shares) $12,800. “Future Horizons and Growth Strategies in the European Cancer Diagnostics Market 2015” is a new five-country ... players and potential entrants; and suggests alternative business expansion strategies for suppliers. RATIONALE The cancer diagnostics market is on the verge ...

... (test volumes, sales forecasts, supplier shares) $4,350. “Future Horizons and Growth Strategies in the French Cancer Diagnostics Market 2015” is a new strategic analysis ... players and potential entrants; and suggests alternative business expansion strategies for suppliers. RATIONALE The cancer diagnostics market is on the verge ...

... (test volumes, sales forecasts, supplier shares) $4,350. “Future Horizons and Growth Strategies in the German Cancer Diagnostics Market 2015” is a new strategic analysis ... players and potential entrants; and suggests alternative business expansion strategies for suppliers. RATIONALE The cancer diagnostics market is on the verge ...

... (test volumes, sales forecasts, supplier shares) $4,350. “Future Horizons and Growth Strategies in the Italian Cancer Diagnostics Market 2015” is a new strategic analysis ... players and potential entrants; and suggests alternative business expansion strategies for suppliers. RATIONALE The cancer diagnostics market is on the verge ...

... (test volumes, sales forecasts, supplier shares) $4,900. “Future Horizons and Growth Strategies in the Japanese Cancer Diagnostics Market 2015” is a new strategic analysis ... players and potential entrants; and suggests alternative business expansion strategies for suppliers. RATIONALE The cancer diagnostics market is on the verge ...

... (test volumes, sales forecasts, supplier shares) $4,350. “Future Horizons and Growth Strategies in the Spanish Cancer Diagnostics Market 2015” is a new strategic analysis ... players and potential entrants; and suggests alternative business expansion strategies for suppliers. RATIONALE The cancer diagnostics market is on the verge ...

... . DataPack (test volumes, sales forecasts, supplier shares) $4,350. “Future Horizons and Growth Strategies in the UK Cancer Diagnostics Market 2015” is a new strategic analysis ... players and potential entrants; and suggests alternative business expansion strategies for suppliers. RATIONALE The cancer diagnostics market is on the verge ...

... . DataPack (test volumes, sales forecasts, supplier shares) $6,400. “Future Horizons and Growth Strategies in the US Cancer Diagnostics Market 2015” is a new strategic analysis ... players and potential entrants; and suggests alternative business expansion strategies for suppliers. RATIONALE The cancer diagnostics market is on the verge ...

... report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget. '2015 Market Segmentation Analysis of the Global Cancer Diagnostics ... , UK, USA WORLDWIDE MARKET OVERVIEW Five-year test volume and sales projections by country. Comprehensive market segmentation analysis, including review of the market dynamics, structure, size ...

... available by country, section, market segment, and can be custom-tailored to your specific information needs and budget. '2015 Market Segmentation Analysis of the ... in Europe. Business Opportunities and Strategic Recommendations Specific new product development opportunities with potentially significant market ...

... is available by section, market segment, and can be custom-tailored to your specific information needs and budget. '2015 Market Segmentation Analysis of the ... in France. Business Opportunities and Strategic Recommendations Specific new product development opportunities with potentially significant market ...

... is available by section, market segment, and can be custom-tailored to your specific information needs and budget. '2015 Market Segmentation Analysis of the ... in Germany. Business Opportunities and Strategic Recommendations Specific new product development opportunities with potentially significant market ...

... is available by section, market segment, and can be custom-tailored to your specific information needs and budget. '2015 Market Segmentation Analysis of the ... in Italy. Business Opportunities and Strategic Recommendations Specific new product development opportunities with potentially significant market ...

... is available by section, market segment, and can be custom-tailored to your specific information needs and budget. '2015 Market Segmentation Analysis of the ... in Japan. Business Opportunities and Strategic Recommendations Specific new product development opportunities with potentially significant market ...

... is available by section, market segment, and can be custom-tailored to your specific information needs and budget. '2015 Market Segmentation Analysis of the ... in Spain. Business Opportunities and Strategic Recommendations Specific new product development opportunities with potentially significant market ...

... . The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget. '2015 Market Segmentation Analysis of the Spanish Cancer Diagnostics ... the rapid market expansion. Spanish Market Overview Five-year test volume and sales projections. Comprehensive market segmentation analysis, including review of the market dynamics, structure ...

... . The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget. '2015 Market Segmentation Analysis of the US Cancer Diagnostics Industry ... and the rapid market expansion. US Market Overview Five-year test volume and sales projections. Comprehensive market segmentation analysis, including review of the market dynamics, structure ...

... ) $21,100. '2015 New Frontiers in Cancer Diagnostics: Global Challenges, Emerging Technologies, Competitive Landscape' is VPGMarketResearch's new study of the major business opportunities emerging in the global cancer diagnostics ... spectroscopy. Extensive listings of companies, universities and research centers developing new cancer diagnostic tests and detection technologies. Competitive Strategies Strategic assessments ...

... .com provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents. The assessments include: Sales ...

... .com provides extensive analyses of major current and emerging suppliers of transfusion diagnostic instruments and reagents. The assessments include: Sales Product ...

... Monoclonal Antibodies, Vaccines 'Global Cancer Immunotherapy Market Outlook 2020' Report Highlight: Introduction & Classification of Cancer Immunotherapy Global Cancer Immunotherapy Pipeline by Company, Indication & Phase Marketed Cancer Immunotherapies ...

... Immunomodulators Cancer Immunomodulators Mechanism Cancer Immunomodulators Clinical Pipeline By Company, Indication & Phase Cancer Immunomodulators Clinical Pipeline: 747 Cancer Immunomodulators Drugs Majority Cancer Immunomodulators in Preclinical Phase: 300 Marketed Cancer Immunomodulators ...

... Cancer Biosimilars Global Cancer Biosimilars Market Dynamics FDA & EMA Guidelines on Development & Marketing of Biosimilars Cancer Biosimilars Clinical Pipeline by Company, Indication & Phase Cancer Biosimilars Clinical Pipeline: 100 Biosimilars Marketed Cancer Biosimilars Clinical Insight Marketed Cancer ...

... report from Venture Planning Group provides strategic assessments of major cancer diagnostic product suppliers and emerging market entrants. The report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios ...

This report provides an overview of the French cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment. Contains 25 pages and 7 tables

This report provides an overview of the German cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment. Contains 25 pages and 7 tables

This report provides an overview of the Italian cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment. Contains 18 pages and 5 tables

This report provides an overview of the Japanese cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment. Contains 23 pages and 6 tables

This report provides an overview of the Spanish cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment. Contains 16 pages and 7 tables

This report provides an overview of the U.K. cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment. Contains 16 pages and 4 tables

This report provides an overview of the US cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment. Contains 40 pages and 7 tables

... position, while immunotherapy for prostate cancer stands at the last positon in the prostate cancer therapeutics market. Prostate Cancer Drugs Analysis: Zytiga leads the prostate cancer drugs market in 2014. Zytiga is facing ... “Global Prostate Cancer Therapeutics Market to 2020” is a 76 page report with 43 Figures and 4 Tables. This report analyses the Prostate Cancer Therapy Market, Prostate Cancer Drugs Market, driving factors and challenges for prostate cancer market ...

... Cancer Monoclonal Antibodies Pipeline: 62 mAb Majority Breast Cancer Monoclonal Antibodies in Preclinical Phase: 17 mAb Marketed Breast Cancer Monoclonal Antibodies: 6 mAb Marketed Breast Cancer Monoclonal Antibodies Clinical Insight Bevacizumab (Avastin) Pertuzumab (Omnitarg, Perjeta) Trastuzumab (Herceptin ...

... personalised medicine and on the key challenges and opportunities in relation to implementation from treating oncologists. Personalised Medicines in Oncology: Assessing ...

... value and benefits of personalised medicine and on the key challenges and opportunities in relation to implementation from treating oncologists. Personalised Medicines in Oncology: Assessing Key Drivers and Challenges ... to development, access and implementation of personalised healthcare strategies. This survey provides US physician insights into personalised medicine within the oncology setting. By understanding what oncologists ...

... the best results. The bottom line here is that cancer immunotherapies will revolutionise cancer treatment and the fortunes of the companies who bring ... -Sarcoma Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA Paolo A. Ascierto, MD, Cancer Immunotherapy and Innovative Therapy Unit Istituto Nazionale ...

... , sales forecasts) $1,850.This report presents a detailed analysis of the Pap Smear/HPV testing market in Europe (France, Germany, Italy, Spain, UK), including clinical significance ... test volume and sales forecasts by country and market segment. The report examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies ...

... Cancer Targeted Therapy Market & Clinical Insight” Report Highlight: Introduction & Categorization of Cancer Targeted Therapies Mechanism of Cancer Targeted Tyrosine Kinase, Vaccines, Oncogenes Inhibitors, Monoclonal Antibodies Cancer Targeted Therapy ...

... Cancer Growth Inhibitors Cancer Growth Inhibitors Clinical Pipeline by Company, Indication & Phase Cancer Growth Inhibitors Clinical Pipeline: 629 Drugs Markets Cancer Growth Inhibitors: 48 Drugs Tyrosine Kinase Dominates Cancer Growth Inhibitors Pipeline: 394 Drugs HDAC Inhibitors Clinical Pipeline: 65 Drugs ...

... “US Thyroid Cancer Market: Trends and Opportunities (2015-2019)” provides an insight into the overall thyroid cancer market of the United States of America. The report analyzes in detail the segments of Thyroid Cancer Market that ... titled “US Thyroid Cancer Market: Trends and Opportunities (2015-2019)” provides an insight into overall thyroid cancer sector of United States of America. The report includes detailed information on market size, installed ...

... cancer therapy can be achieved. “Cancer Nanomedicine Market & Pipeline Insight 2015” Report Highlight Nanomedicine for Cancer Therapies Cancer Nanoparticles Drug Delivery Systems Classification Mechanism of Cancer Nanomedicine Therapy Cancer Nanomedicine Clinical Pipeline Overview Cancer Nanomedicine ...